| Spirig HealthCare AG - Tadalafil Spirig HC, 5 mg, Filmtabletten | | 67625 | | 02 | | Tadalafil Spirig HC, 5 mg | | Filmtabletten | | G04BE08 | | Tadalafil | | 23.07.2020 | | |
| | Composition | | tadalafilum 5 mg, lactosum monohydricum 57.3 mg, croscarmellosum, natrii laurilsulfas, hydroxypropylcellulosum, polysorbatum 80, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 840 µg, E 171, triacetinum, E 172 (flavum), talcum, pro compresso obducto corresp., natrium 419.6 µg. | | Packungsbestandteile | | Comprimés filmés | | | | Principe actif | Concentr. |
|---|
| Tadalafilum | 5 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | Cellulosum Microcristallinum | | | | Croscarmellosum | | | | E 171 | | color. | | E 172 | | color. | | Hydroxypropylcellulosum | | | | Hypromellosum | | Überzug | | Lactose Monohydrate | 840 µg | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Polysorbatum 80 | | | | Pro Compresso Obducto | | | | Talcum | | | | Triacetinum | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 013 | 28 | | | B | | Non | | 014 | 84 | | | B | | Non |
|
|
